Drugs / Sto M Tab.
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT07631065 | Jun 2026 → Feb 2028 expected | chronic gastritis | Mather's Pharm. Co., Ltd. | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sto M Tab. | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07631065 ↗ |
| Route | Oral | “Sto M Tab., oral” NCT07631065 ↗ |